GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Botanix Pharmaceuticals Ltd (OTCPK:BXPHF) » Definitions » Net Interest Income (for Banks)

BXPHF (Botanix Pharmaceuticals) Net Interest Income (for Banks)


View and export this data going back to 2019. Start your Free Trial

What is Botanix Pharmaceuticals Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Botanix Pharmaceuticals Business Description

Traded in Other Exchanges
Address
41 - 47 Colin Street, Suite 3, West Perth, WA, AUS, 6005
Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1204 - Atopic Dermatitis, and BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is Derived from Australia.